Klingstedt Therése, Shirani Hamid, Mahler Jasmin, Wegenast-Braun Bettina M, Nyström Sofie, Goedert Michel, Jucker Mathias, Nilsson K Peter R
Department of Chemistry, Linköping University, SE-581 83 Linköping (Sweden).
Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen (Germany).
Chemistry. 2015 Jun 15;21(25):9072-82. doi: 10.1002/chem.201500556. Epub 2015 May 26.
The accumulation of protein aggregates is associated with many devastating neurodegenerative diseases and the existence of distinct aggregated morphotypes has been suggested to explain the heterogeneous phenotype reported for these diseases. Thus, the development of molecular probes able to distinguish such morphotypes is essential. We report an anionic tetrameric oligothiophene compound that can be utilized for spectral assignment of different morphotypes of β-amyloid or tau aggregates present in transgenic mice at distinct ages. The ability of the ligand to spectrally distinguish between the aggregated morphotypes was reduced when the spacing between the anionic substituents along the conjugated thiophene backbone was altered, which verified that specific molecular interactions between the ligand and the protein aggregate are necessary to detect aggregate polymorphism. Our findings provide the structural and functional basis for the development of new fluorescent ligands that can distinguish between different morphotypes of protein aggregates.
蛋白质聚集体的积累与许多毁灭性的神经退行性疾病相关,并且有人提出不同的聚集形态型的存在可以解释这些疾病所报道的异质表型。因此,开发能够区分此类形态型的分子探针至关重要。我们报道了一种阴离子四聚体寡聚噻吩化合物,它可用于对不同年龄转基因小鼠中存在的β-淀粉样蛋白或tau聚集体的不同形态型进行光谱鉴定。当沿共轭噻吩主链的阴离子取代基之间的间距改变时,配体在光谱上区分聚集形态型的能力降低,这证实了配体与蛋白质聚集体之间特定的分子相互作用对于检测聚集体多态性是必要的。我们的研究结果为开发能够区分蛋白质聚集体不同形态型的新型荧光配体提供了结构和功能基础。